论文部分内容阅读
目的对甲基强的松龙冲击治疗小儿神经免疫性疾病的临床效果进行分析和评价。方法自2010年1月至2012年1月,我院我科收治神经免疫性疾病患儿60例,将所有患儿随机分成两组,即实验组和对照组。其中实验组患儿35例,对其行甲基强的松龙冲击治疗,对照组患儿25例,对其采取常规治疗。观察两组的临床疗效,并作出分析和评价。结果两组相比,实验组的临床疗效要优于对照组,差异有统计学意义(P<0.01);实验组的显效率要高于对照组,差异有统计学意义(P>0.05)。结论甲基强的松龙冲击治疗小儿神经免疫性疾病,效果显著,值得临床应用和推广。
Objective To analyze and evaluate the clinical effect of methylprednisolone therapy on children with neuroimmune diseases. Methods From January 2010 to January 2012, 60 children with neuroimmune diseases were treated in our department. All children were randomly divided into two groups, experimental group and control group. Among them, 35 cases were treated with methylprednisolone in the experimental group and 25 cases in the control group. Conventional treatment was given to them. The clinical effects of the two groups were observed and analyzed and evaluated. Results Compared with the control group, the clinical efficacy of the experimental group was better than that of the control group (P <0.01). The effective rate of the experimental group was higher than that of the control group, the difference was statistically significant (P> 0.05). Conclusion Methylprednisolone treatment of children with neurological immune disease, the effect is significant, it is worthy of clinical application and promotion.